Due to activated tumor-associated CD11c+DCs, which higher expression of CD86, we further evaluated the expression of tumor-associated CD86+DCs (CD45+CD11b+CD11c+CD86+) within the tumor tissue by flow cytometry. This evidence concerns the gene ITGAX and neoplasm.